Berger Mark Stanley (CIK 1700283) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-27). Recent activity: Sell GNPX (7,168 shares), Buy GNPX (28,500 shares), Sell GNPX (4,500 shares), Sell GNPX (585 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-27 | Genprex, Inc. (GNPX) | Chief Medical Officer | Sell | 7,168 | $14,336 |
| 2025-12-23 | Genprex, Inc. (GNPX) | Chief Medical Officer | Buy | 28,500 | $0 |
| 2025-07-01 | Genprex, Inc. (GNPX) | Chief Medical Officer | Sell | 4,500 | $1,035 |
| 2025-02-19 | Genprex, Inc. (GNPX) | Chief Medical Officer | Sell | 585 | $240 |
Source: SEC Form 4 filings · as of 2026-02-27